The mission of CasInvent Pharma is to bring new therapeutic options for the treatment of selected leukemias to market. We are developing highly selective small molecule inhibitors of casein kinase I (CK1), and our main development program is focused on the identification of new drugs for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL). CasInvent Pharma was established in 2020 as a spin-off company of Masaryk University in cooperation with the investment partner i&i Prague.
| Website | https://www.casinvent.com/ |
| Employees | 7 (2 on RocketReach) |
| Founded | 2020 |
| Phone | +420 728 995 850 |
| Industry | Pharmaceutical Manufacturing |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences, Lilly India +39 more (view full list) |
Looking for a particular CasInvent Pharma employee's phone or email?
CasInvent Pharma Questions
2 people are employed at CasInvent Pharma.
Top CasInvent Pharma Employees
-
Zuzana Jasenakova
Senior Biologist at CasInvent Pharma
South Moravian Region, Czechia1 -
Jiří Švejkar
Organický chemik at CasInvent Pharma
South Moravian Region, Czechia
Related Companies
G2Crowd Trusted
300K+
Plugin Users
